A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals

Autor: Andorf, Sandra, Purington, Natasha, Kumar, Divya, Long, Andrew, O'Laughlin, Katherine L., Sicherer, Scott, Sampson, Hugh, Cianferoni, Antonella, Whitehorn, Terri Brown, Petroni, Daniel, Makhija, Melanie, Robison, Rachel G., Lierl, Michelle, Logsdon, Stephanie, Desai, Manisha, Galli, Stephen J., Rael, Efren, Assa'ad, Amal, Chinthrajah, Sharon, Pongracic, Jacqueline, Spergel, Jonathan M., Tam, Jonathan, Tilles, Stephen, Wang, Julie, Nadeau, Kari
Zdroj: In EClinicalMedicine January 2019 7:27-38
Databáze: ScienceDirect